INFRASTRUCTURE: By offering turnkey labs and offices, conference facilities and ample coworking space, Park Basel Area creates the ideal environment for ideas to grow and flourish.
> Read moreSpace
SPACE FOR INNOVATION
SERVICE PORTFOLIO: Thanks to the target-oriented scope of services, support and coaching, residents at Park Basel Area can focus on what is key for them – perfecting their ideas until they are ready to market.
> Read more
SPACE FOR ADVANCEMENT
ECOSYSTEM: As a globally leading life sciences cluster, the Greater Basel Area is the perfect breeding ground for revolutionary development and disruption. Park Basel Area gives its residents every opportunity to take root and access the various resources of this dynamic hotspot.
> Read moreFOCUS AREAS
PRECISION MEDICINE
Customized healthcare, taking advantage of digitalization in combination with health-oriented life sciences and biomedical engineering.
> Read more
HEALTH-ORIENTED LIFE SCIENCES
Life sciences innovations with a major focus on therapeutics and diagnostics.
> Read more
BIOMEDICAL ENGINEERING
The interface between medicine and natural sciences with the objective to improve medical technologies.
> Read moreINNOVATION LOG
23.11.2018
150 Scientists Working on…
The community at Switzerland Innovation Park Basel Area keeps growing. We are delighted to present our…
> Read more
14.11.2018
3 keys to securing…
Catalyze is one of the newest residents at Switzerland Innovation Park Basel Area and a market…
> Read more
01.11.2018
Non-dilutive Funding for Life…
Access to funding is commonly one of the main challenges for entrepreneurs. Catalyze is one of…
> Read more
18.09.2018
SWITZERLAND INNOVATION PARK BASEL…
The Park Basel Area community is growing – we are delighted to present our new residents.…
> Read more
23.08.2018
Allschwil – Birthplace of…
Located in the midst of the Life Sciences Cluster Basel, Allschwil is a great location for…
> Read more
08.08.2018
Register for the DBE…
On September 5, 2018, the Department of Biomedical Engineering (DBE) is open to the public. Guests,…
> Read more
Newsby BaselArea.swiss
14.03.2019
Axovant bietet Stammaktien an
Das Basler Pharmaunternehmen Axovant Sciences bietet seine Stammaktien für den öffentlichen Handel an. Es rechnet mit…
> Read more
12.03.2019
Roche führt Schweiz bei…
In keinem Land in Europa wurden 2018 mehr Patente im Verhältnis zur Einwohnerzahl eingereicht als in…
> Read more
05.03.2019
New at Switzerland Innovation…
The biopharmaceutical company SunRegen Healthcare develops a therapy for neurodegenerative eye diseases like Optic Atrophy. The…
> Read more